Unilever explores bid for $4bn supplement maker Thorne
Summary
Unilever is exploring a potential roughly $4 billion bid for Thorne, a supplements company, as it pushes deeper into health and wellness. The interest follows Unilever’s portfolio shift after separating its food business.
Why it matters
Buying into supplements would reweight Unilever’s growth engine toward consumer health and impose new operational and regulatory demands across its supply chain.